Epigenetic Regulation and Targeted Therapy in Gall Bladder Cancer
Journal of Biochemical and Molecular Toxicology · 2025
DOI: 10.1002/jbt.70403 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Devbrat Singh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Amity Institute of Biotechnology, Amity University Uttar Pradesh Lucknow Campus, Lucknow, India. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Gallbladder Neoplasms, Molecular Targeted Therapy, Gene Expression Regulation, Neoplastic. Die Arbeit nennt 95 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Gall bladder cancer is a formidable malignancy known for its aggressive nature and often late‐stage diagnosis. In recent years, oncology has changed basic assumptions towards personalized and targeted therapies. Significant emphasis has been paid to research and clinical contexts about DNA methylation, histone changes, and microRNA alterations as key epigenetic pathways linked to the development of gall bladder cancer. The review delves into the potential of epigenetic markers as diagnostic and prognostic tools and discusses their utility in finding novel therapeutic targets. Targeted therapies have demonstrated effectiveness in addressing various types of cancer, and gall bladder cancer is no exception. The recent advancements in targeted therapies tailored for gall bladder cancer have been elaborated, underscoring the vital role of precision medicine in customizing treatment plans to suit individual patients. The review also examines the challenges and opportunities associated with the development of therapies specifically designed to target epigenetic changes, potentially offering treatment options that are both more efficacious and less toxic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Amity Institute of Biotechnology, Amity University Uttar Pradesh Lucknow Campus, Lucknow, India.
ORCID-Profile: Sayali Mukherjee
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Singh, D., & Mukherjee, S. (2025). Epigenetic Regulation and Targeted Therapy in Gall Bladder Cancer. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70403
Vancouver
Singh D, Mukherjee S. Epigenetic Regulation and Targeted Therapy in Gall Bladder Cancer. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70403
BibTeX
@article{Singh2025,
author = {Singh, Devbrat and Mukherjee, Sayali},
title = {Epigenetic Regulation and Targeted Therapy in Gall Bladder Cancer},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
doi = {10.1002/jbt.70403}
}
EUVIMED